Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
Unique Pharmaceutical Laboratories has issued a nationwide recall for specific batches of its 5-mg cetirizine hydrochloride tablets. This medication, a common generic antihistamine, was found to contain mislabeled pills. A pharmacy technician discovered the error during routine counting after noticing pills of an incorrect color mixed into the bottles.
The bottles may be contaminated with ranitidine. This substance was formerly sold under the brand name Zantac and is used for heartburn and indigestion. This mix-up presents a significant risk to individuals who possess a hypersensitivity to ranitidine. In some cases, ingestion could lead to life-threatening reactions including anaphylaxis.
While there are currently no reported illnesses linked to this specific error, the recall is an urgent measure to prevent accidental exposure. Consumers are urged to check their medication bottles immediately against the lot numbers provided by the FDA. Retailers sold these items across the country, making it critical for anyone who keeps generic allergy medicine on hand to verify their supply.
If you have questions or need to confirm if your specific bottle is affected, you should reach out to Rising Pharma Holdings Inc. They have established a dedicated line at 1-844-874-7464 to handle inquiries during standard business hours. You may also contact them via email at pv@risingpharma.com or qa@risingpharma.com for further guidance.
Do not consume any tablets that match the recalled lot numbers. If you believe you have already taken a contaminated pill and experience any unusual symptoms, seek medical advice or report the incident to the FDA through their online portal. Maintaining awareness of these batch numbers is the most effective way to ensure your safety until the recalled stock is removed from circulation.